BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20801436)

  • 1. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders.
    Kim CH; Howles CM; Lee HA
    Fertil Steril; 2011 Feb; 95(2):679-83. PubMed ID: 20801436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled ovarian hyperstimulation for low responders in in vitro fertilization/intracytoplasmic sperm injection: a low-dose flare protocol.
    Datta AK; Vitthala S; Tozer A; Zosmer A; Sabatini L; Davis C; Al-Shawaf T
    Fertil Steril; 2011 Apr; 95(5):1809-12. PubMed ID: 21168131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment.
    Sunkara SK; Coomarasamy A
    Fertil Steril; 2011 Jun; 95(8):e73-4; author reply e75. PubMed ID: 21601849
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.
    Kim CH; Jeon GH; Cheon YP; Jeon I; Kim SH; Chae HD; Kang BM
    Fertil Steril; 2009 Nov; 92(5):1758-60. PubMed ID: 19523618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study.
    Blockeel C; Riva A; De Vos M; Haentjens P; Devroey P
    Fertil Steril; 2011 Apr; 95(5):1714-9.e1-2. PubMed ID: 21300334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study.
    Massin N; Cedrin-Durnerin I; Coussieu C; Galey-Fontaine J; Wolf JP; Hugues JN
    Hum Reprod; 2006 May; 21(5):1204-11. PubMed ID: 16476678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
    Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Kim CH; Kim SR; Cheon YP; Kim SH; Chae HD; Kang BM
    Fertil Steril; 2009 Dec; 92(6):2082-4. PubMed ID: 19589522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
    Elassar A; Mann JS; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jan; 95(1):324-6. PubMed ID: 20797708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome.
    Kok JD; Looman CW; Weima SM; te Velde ER
    Fertil Steril; 2006 Apr; 85(4):918-24. PubMed ID: 16580375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antral Follicle Priming Before Intracytoplasmic Sperm Injection in Previously Diagnosed Low Responders: A Randomized Controlled Trial (FOLLPRIM).
    Escriva AM; Diaz-Garcia C; Monterde M; Rubio JM; Pellicer A
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2597-605. PubMed ID: 25955224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical outcomes of intracytoplasmic sperm injection (ICSI) and ISCI following fertilization failure in conventional IVF: a comparative analysis].
    Sun L; Liu P; Quan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):993-5. PubMed ID: 19460729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels.
    Weissman A; Horowitz E; Ravhon A; Golan A; Levran D
    Gynecol Endocrinol; 2011 Dec; 27(12):1014-7. PubMed ID: 21500990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study.
    Päkkilä M; Räsänen J; Heinonen S; Tinkanen H; Tuomivaara L; Mäkikallio K; Hippeläinen M; Tapanainen JS; Martikainen H
    Hum Reprod; 2005 Aug; 20(8):2211-4. PubMed ID: 15817582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
    Balasch J; Fábregues F; Peñarrubia J; Carmona F; Casamitjana R; Creus M; Manau D; Casals G; Vanrell JA
    Hum Reprod; 2006 Jul; 21(7):1884-93. PubMed ID: 16517559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
    González-Comadran M; Durán M; Solà I; Fábregues F; Carreras R; Checa MA
    Reprod Biomed Online; 2012 Nov; 25(5):450-9. PubMed ID: 22999555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
    Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.